Dynavax Technologies
DVAX
#5494
Rank
NZ$2.22 B
Marketcap
NZ$18.98
Share price
-0.09%
Change (1 day)
-13.77%
Change (1 year)

Earnings for Dynavax Technologies (DVAX)

Earnings in 2025 (TTM): -NZ$63.57 Million

According to Dynavax Technologies 's latest financial reports the company's current earnings are NZ$0.33 Billion. In 2024 the company made an earning of NZ$65.18 Million, an increase over its 2023 earnings that were of NZ$4.13 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Dynavax Technologies from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$63.57 Million-197.5%
2024 NZ$65.18 M1475.31%
2023 NZ$4.13 M-99.2%
2022 NZ$0.52 B238.78%
2021 NZ$0.15 B-257.89%
2020 -NZ$97.27 Million-58.58%
2019 -NZ$0.24 Billion-9.32%
2018 -NZ$0.26 Billion60.44%
2017 -NZ$0.17 Billion-15.8%
2016 -NZ$0.2 Billion4.22%
2015 -NZ$0.19 Billion16.54%
2014 -NZ$0.16 Billion37.09%
2013 -NZ$0.12 Billion
2010 -NZ$82.4 Million214.85%
2009 -NZ$26.18 Million-37.33%
2008 -NZ$41.77 Million-66.07%
2007 -NZ$0.13 Billion16.92%
2006 -NZ$0.11 Billion170.36%
2005 -NZ$38.94 Million33.39%
2004 -NZ$29.2 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Agenus
AGEN
NZ$35.77 M-160.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$3.29 B-5,718.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$39.97 B-68,236.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$17.11 B-29,272.57%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$22.66 B-38,727.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
GlaxoSmithKline
GSK
NZ$16.14 B-27,610.92%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
NZ$20.52 B-35,074.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$3.06 B-5,328.99%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
NZ$14.27 B-24,427.20%๐Ÿ‡บ๐Ÿ‡ธ USA